KCNT1 and epilepsy: KDT and quinidine confer different therapeutic advantages depending on the KCNT1 variant: KDT was effective regardless of the variant and especially effective in patients with functional domain variant-related epilepsy, whereas quinidine was effective in patients with non-functional domain variant-related epilepsy.